NCT06558019View on ClinicalTrials.gov

Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence

Not yet recruitingOBSERVATIONAL
Enrollment

509

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Ovarian Cancer
Trial Locations (1)

Unknown

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Lei Li

OTHER

NCT06558019 - Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence | Biotech Hunter | Biotech Hunter